Newsfeeds Archive - Spark Newswire

2 minute read

Smith+Nephew’s PICO Single Use Negative Pressure Wound Therapy System Provides Better Clinical Outcomes Versus Standard Of Care According To Uk National Institute For Health And Care Excellence

April 4, 11:22 AM

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO

SNN

3 minute read

Smith+Nephew Announces Commercial Launch Of Its AETOS Shoulder System For Anatomic And Reverse Shoulder Replacement At AAOS 2024 Annual Meeting

By Benzinga Newsdesk

February 13, 9:10 AM

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D

SNN

2 minute read

Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday

By Lisa Levin

October 4, 8:12 AM

Citigroup raised the price target for LyondellBasell Industries N.V. (NYSE: LYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell Industries shares gained 0.4% to close at $93.79 on Tuesday.

BGS

1 minute read

Smith & Nephew Raises Revenue Growth Outlook After Strong 1H Performance, Sports Medicine and Wound Management Show Strength

By Vandana Singh

August 3, 1:32 PM

Smith & Nephew PLC (NYSE: SNN) reported improved revenue, profit, and margin in the

SNN

31 minute read

Earnings

Earnings Scheduled For August 3, 2023

By Benzinga Insights

August 3, 6:59 AM

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

AAOI

1 minute read

AstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday

By Lisa Levin

July 3, 10:41 AM

U.S. stocks traded mixed, with the Dow Jones dropping around 30 points on Monday. Here are some big stocks recording losses in today’s session. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares dipped 36.4% to $17.60.

ASTC

2 minute read

Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck

By AJ Fabino

June 29, 1:03 PM

Industry giant Morgan Stanley (NYSE:MS) is shaking up its model for income-focused investors, indicating a strategic move towards…

AMGN

2 minute read

Smith+Nephew Announces 510(K) Clearance Of Its AETOS Shoulder System For Anatomic And Reverse Shoulder Replacement

By Benzinga Newsdesk

June 12, 10:03 AM

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its AETOS Shoulder System.Designed

SNN

1 minute read

News

Smith+Nephew Helps Personalize Robotically-Enabled Surgery With AI-Powered Planning Software And Data Visualization Platform

By Happy Mohamed

May 16, 8:13 AM

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today introduces two key products that close the feedback loop for its robotics and digital surgery portfolio – Personalized Planning

SNN

2 minute read

Smith+Nephew Receives Innovative Technology Contract From Vizient For PICO Single Use Negative Pressure Wound Therapy Systems

By Benzinga Newsdesk

May 2, 8:12 AM

Contract awarded for products that bring improvement to healthcare industryLONDON, May 2, 2023 /PRNewswire/ -- Smith+Nephew ((LSE: SN, NYSE:SNN), the global medical technology company, today announces its PICO Single Use

SNN